Morishita Jintan Co., Ltd.

4524.T
Drug Manufacturers - Specialty & Generic
2026/08/21 Updated
Market Cap: $57.7M (¥9.2B)
Stock Price: $14.07 (¥2,237)
Exchange Rate: 1 USD = ¥158.98

Partial Revision of the Basic Policy on the Establishment of Internal Control Systems

Revised the basic policy of the internal control system. Aims to strengthen governance across the group by enhancing the independence of the Audit Committee and Internal Audit Office, expanding the whistleblowing system, and improving the reliability of financial reporting.

Importance:
Page Updated: July 12, 2026
IR Disclosure Date: June 10, 2026
Other

Key Figures

  • Basic policy of internal control system revision
  • Strengthened collaboration between the Audit Committee and Internal Audit Office
  • Upgrading and thorough dissemination of the whistleblowing policy

AI要約

Rationale for the Revision

Morishita Jintan has been continuously advancing the sophistication of internal controls and risk management in response to evolving corporate governance requirements and the progress of group management. This revision aims to strengthen the group-wide compliance framework and the collaboration with audits, enhance the reliability of financial reporting, and build a management foundation that supports sustainable increases in corporate value.

Future Actions

The basic policy after revision will be further enhanced through operation and monitoring, and understanding and effectiveness will be ensured through internal training and other measures.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Morishita Jintan Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →